Ocular Drug Delivery group (ODD)

The Ocular Drug Delivery (ODD) group develops advanced drug delivery methods for targeted and prolonged drug delivery to both the anterior and posterior segments of the eye. Furthermore, we use computational tools for drug development and preclinical-to-clinical translation to build a quantitativ...

EDCMET

01.01.2019 - 31.12.2023
Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways

Epilepsy Research

Our goal is to
a) understand the molecular and cellular mechanisms of epileptogenesis after traumatic brain injury,
b) to develop interventions to prevent epileptogenesis or alleviate the disease severity.

Annakaisa Haapasalo Group (Molecular Neurodegeneration)

01.06.2015 -
Our research focus lies in the genetic background and molecular mechanisms underpinning neurodegenerative diseases, especially frontotemporal dementia (FTD). To this end, we utilize a variety of in vitro and in vivo model systems and patient-derived cells, clinical samples and data. We are especi...

Sweelin Chew

Postdoctoral Researcher , A.I. Virtanen Institute for Molecular Sciences

Anna Kårlund

Postdoctoral Researcher , Institute of Public Health and Clinical Nutrition

Neurobiology of disease

24.10.2017 -
The main goal of our research is to understand the mechanisms that lead to neurodegenerative diseases and to identify novel therapeutic approaches for them. We are interested in the effects of environmental factors (such as air pollution and viral infections) and lifestyle factors on brain healt...